Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q1 FY23 results · Apr–Jun 2022
Krishna Institute of Medical Sciences reported revenue from operations of ₹495.51 crore (up 4.7% from Q1 FY22) and net profit of ₹79.25 crore (down 13.9% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 495.51 | 473.18 | +4.7% | 372.34 | +33.1% |
| Other income | 5.33 | 4.27 | +24.9% | 8.19 | −34.9% |
| Total income | 500.85 | 477.45 | +4.9% | 380.53 | +31.6% |
| Profit before tax | 107.36 | 124.53 | −13.8% | 99.27 | +8.1% |
| Net profit for the period | 79.25 | 92.03 | −13.9% | 83.32 | −4.9% |
| Attributable to shareholders of the company | 69.96 | 89.13 | −21.5% | 80.69 | −13.3% |
| EPS, basic (₹) | 8.74 | 11.48 | −23.9% | 10.08 | −13.3% |
| Net margin (%) | 16.0 | 19.4 | 22.4 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 262.95 | 331.51 | −20.7% | 254.50 | +3.3% |
| Other income | 3.71 | 4.02 | −7.7% | 7.71 | −52.0% |
| Total income | 266.66 | 335.53 | −20.5% | 262.21 | +1.7% |
| Profit before tax | 70.02 | 102.13 | −31.4% | 84.11 | −16.7% |
| Net profit for the period | 52.12 | 76.16 | −31.6% | 63.91 | −18.4% |
| EPS, basic (₹) | 6.51 | 9.81 | −33.6% | 7.99 | −18.5% |
| Net margin (%) | 19.8 | 23.0 | 25.1 |
Consolidated
- Filed with BSE
- 12 Aug 2022, 10:07 IST
- Board meeting
- 10 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Aug 2022, 10:07 IST
- Board meeting
- 10 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE